Link to Pubmed [PMID] – 32793765
Link to DOI – 10.1093/ofid/ofaa267
Open Forum Infect Dis 2020 Aug; 7(8): ofaa267
Syndromic respiratory panels are increasingly used worldwide. Their performance for detection of Bordetella pertussis needs to be evaluated. We found that the FilmArray Respiratory Panel 2plus (RP2+) assay, which uses the pertussis toxin promoter target for B. pertussis, can only detect highly charged samples. Negative RP2+ results should not be interpreted as an absence of B. pertussis in clinical samples.